Home NDC 63402-206 Aptiom
Product NDC 63402-206
11-digit product format 634020206
Labeler code 63402
Product ID 63402-206_3af99c5d-50e2-4336-8a5e-e93b6cf3618a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ESLICARBAZEPINE ACETATE
Dosage form TABLET
Route ORAL
Labeler Sumitomo Pharma America, Inc.
Application NDA022416
Marketing category NDA
Marketing start 2014-04-07
Substance ESLICARBAZEPINE ACETATE
Active strength 600 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022416-001 APTIOM ESLICARBAZEPINE ACETATE 200MG TABLET / ORAL AB RLD 2013-11-08 N022416-002 APTIOM ESLICARBAZEPINE ACETATE 400MG TABLET / ORAL AB RLD 2013-11-08 N022416-003 APTIOM ESLICARBAZEPINE ACETATE 600MG TABLET / ORAL AB RLD 2013-11-08 N022416-004 APTIOM ESLICARBAZEPINE ACETATE 800MG TABLET / ORAL AB RLD, RS 2013-11-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 32 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022416-001 APTIOM 200MG TABLET / ORAL AB RLD 2013-11-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022416-002 APTIOM 400MG TABLET / ORAL AB RLD 2013-11-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022416-003 APTIOM 600MG TABLET / ORAL AB RLD 2013-11-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022416-004 APTIOM 800MG TABLET / ORAL AB RLD, RS 2013-11-08 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 132 observed states.
Observed Orange Book patent history# Patent history page 1 of 56 · 2,232 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022416-001 9206135 2026-04-21 Drug substance 2016-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 9643929 2026-04-21 Drug product 2017-06-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 9763954 2028-09-13 U-2123 2017-10-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 10912781 2028-10-23 Drug product 2021-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 9566244 2028-10-23 Drug product 2017-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 8372431 2030-04-17 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 9750747 2032-08-24 U-2041 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-001 9750747 2032-08-24 U-2121 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9206135 2026-04-21 Drug substance 2016-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9643929 2026-04-21 Drug product 2017-06-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9763954 2028-09-13 U-2123 2017-10-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 10912781 2028-10-23 Drug product 2021-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9566244 2028-10-23 Drug product 2017-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 8372431 2030-04-17 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9750747 2032-08-24 U-2121 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-002 9750747 2032-08-24 U-2041 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9206135 2026-04-21 Drug substance 2016-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9643929 2026-04-21 Drug product 2017-06-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9763954 2028-09-13 U-2123 2017-10-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 10912781 2028-10-23 Drug product 2021-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9566244 2028-10-23 Drug product 2017-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 8372431 2030-04-17 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9750747 2032-08-24 U-2121 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-003 9750747 2032-08-24 U-2041 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9206135 2026-04-21 Drug substance 2016-05-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9643929 2026-04-21 Drug product 2017-06-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9763954 2028-09-13 U-2123 2017-10-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 10912781 2028-10-23 Drug product 2021-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9566244 2028-10-23 Drug product 2017-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 8372431 2030-04-17 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9750747 2032-08-24 U-2041 2017-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022416-004 9750747 2032-08-24 U-2121 2017-09-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 10675287 2025-05-06 U-2831 2020-06-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 10675287 2025-05-06 U-2041 2020-06-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 10695354 2025-05-06 U-2831 2020-06-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 10695354 2025-05-06 U-2501 2020-06-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 10702536 2025-05-06 U-2501 2020-07-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 11364247 2025-05-06 U-2501 2022-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 11364247 2025-05-06 U-2831 2022-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022416-001 9206135 2026-04-21 Drug substance 2016-05-20 31067a03dcf5…
Additional Listing Data#
Finished product Yes
Brand name base Aptiom
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ESLICARBAZEPINE ACETATE 600 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination BEA68ZVB2K Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1482507 Internal RxNorm lookup 1482513 Internal RxNorm lookup 1482515 Internal RxNorm lookup 1482517 Internal RxNorm lookup 1482521 Internal RxNorm lookup 1482523 Internal RxNorm lookup 1482525 Internal RxNorm lookup 1482527 Internal RxNorm lookup 1491642 Internal RxNorm lookup 1491643 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63402-206-07 Aptiom 7 in 1 BLISTER PACK TABLET 7 16 63402-206-28 Aptiom 4 in 1 CARTON TABLET 4 16 63402-206-60 Aptiom 60 in 1 BOTTLE TABLET 60 16
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63402-206 APTIOM (ESLICARBAZEPINE ACETATE) TABLET APTIOM (ESLICARBAZEPINE ACETATE) KIT [SUMITOMO PHARMA AMERICA, INC.] 16 Current NDC, Legacy NDC, 3 package rows 20231205_3d0c9554-eaeb-4694-8089-00133fcadce3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aptiom ESLICARBAZEPINE ACETATE Sumitomo Pharma America, Inc. 3d0c9554-eaeb-4694-8089-00133fcadce3 2023-11-10 Warnings, Adverse reactions Exact identifier application applno (NDA): 022416 application number: NDA022416 ndc (product): 63402-206
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63402-206-07 63402020607 7 in 1 BLISTER PACK Historical 63402-206-28 63402020628 4 BLISTER PACK in 1 CARTON (63402-206-28) / 7 TABLET in 1 BLISTER PACK (63402-206-07) 4 blister pack 2014-04-07 0000-00-00 No No Current 63402-206-60 63402020660 60 TABLET in 1 BOTTLE (63402-206-60) 60 tablet 2014-04-07 0000-00-00 No No Current